Sitaxsentan: a selective endothelin-A receptor antagonist, for the treatment of pulmonary arterial hypertension.
Barst, Robyn J
Sitaxsentan: a selective endothelin-A receptor antagonist, for the treatment of pulmonary arterial hypertension. [electronic resource] - Expert opinion on pharmacotherapy Jan 2007 - 95-109 p. digital
Publication Type: Comparative Study; Journal Article; Review
1744-7666
10.1517/14656566.8.1.95 doi
Endothelin A Receptor Antagonists
Humans
Hypertension, Pulmonary--drug therapy
Isoxazoles--pharmacology
Multicenter Studies as Topic
Randomized Controlled Trials as Topic
Receptor, Endothelin A--physiology
Thiophenes--pharmacology
Sitaxsentan: a selective endothelin-A receptor antagonist, for the treatment of pulmonary arterial hypertension. [electronic resource] - Expert opinion on pharmacotherapy Jan 2007 - 95-109 p. digital
Publication Type: Comparative Study; Journal Article; Review
1744-7666
10.1517/14656566.8.1.95 doi
Endothelin A Receptor Antagonists
Humans
Hypertension, Pulmonary--drug therapy
Isoxazoles--pharmacology
Multicenter Studies as Topic
Randomized Controlled Trials as Topic
Receptor, Endothelin A--physiology
Thiophenes--pharmacology